Cancer Share Your Knowledge, Story or Survival Experience

Contribute Articles - Cancer Diagnosis, Treatment and Surgery Articles
  

Home | Submit Articles | Login   
 
ALL Cancers BREAST CERVICAL LEUKEMIA LUNG MESOTHELIOMA PROSTATE SURGERY
 
 

Umbilical Cord Blood to Treat Patients With Acute Myeloid Leukemia Treatment

BY: Ritu Choudhary | Category: Leukemia | Submitted: 2010-10-10 18:28:12
•    Post a Comment

•    Read Comments

•    Print This Article

   No Photo

Help others find this article:

ADD TO StumbleUpon ADD TO DEL.ICIO.US ADD TO DIGG Share with FACEBOOK
Show All Social Bookmarks



Stem cells can be made from umbilical cord blood. Acute myeloid leukemia (AML) occurs mostly in the elderly. Every year about thousands of people across the world suffer from leukemia. AML has been observed to be very common in people above the age of fifty five and their treatment using chemotherapy and radiotherapy is the last resort. But treatment of leukemia by vaccination is a god's gift for such patients. Cultured stem cells have power to curb the recurrence of cancer of patients who has already been successfully treated with cancer.

Leukemia is often returned
With chemotherapy, sometimes followed by a stem cell transplant, doctors try to destroy the proliferating white blood cells and thus to cure leukemia. In many cases this seems initially to be working well. But older patients are usually not candidates for a stem cell leukemia, and with them the often aggressive. The majority of the over-sixties, the disease therefore returned within three years and leads to death. Better treatment is therefore urgently needed, find the UMC, which is therefore a potential treatment using cord blood has been addressed.

Chemotherapy is not enough
Currently Leukemia patients first treated with chemotherapy for invasive white blood cells to eradicate. Most of the time there are some tumor cells behind, which then quickly multiply. After the chemotherapy is therefore actually still be handed a further blow, so that the latter tumor cells disappear. NK cells seem ideal candidates to pull it off. "

Stem cells from umbilical cord
Natural Killer Cells can also gain from donor blood, thus experiments yielded good results in patients with acute myeloid leukemia (AML). It is also very difficult to estimate adequately the dosage of killer cells from donor blood. Therefore follows the Laboratory of Hematology, in close cooperation with the firm Glycostem Therapeutics. They use stem cells from the umbilical cord and cultures through a special procedure for killer cells.

Regenerative Medicine
The cultured killer cells eliminate damaged, infected and abnormal cells and leave healthy cells alone. If the experiment is successful, the researched killer cells committed to other applications such as regenerative medicine

A team of researchers has managed to produce a personalized leukemia vaccine that helps in the immunization of the patients. This is a first in the development of cancer vaccines. The phase 1 / 2 clinical study was performed on adult patients with acute myeloid leukemia (AML) who have received chemotherapy but had a high risk of relapse. Acute myeloid leukemia (AML) in adults is an aggressive blood cancer which mainly affects older people over 60. Although the disease in most patients can be brought under control by chemotherapy, but relapse in them (relatively quickly) due to residual, albeit are often not numerous. The examined cell vaccine is custom made for the patient, ie based on the immune cells of the patient. The success, according to the researchers attributed to their choice of a powerful immune stimulant ingredient, derived from a component of cancer cells in combination with powerful immune cells. For the analysis, a team has worked very closely with the teams from Japan, United Kingdom and of Netherlands. The researchers have tested the vaccine but are currently only in small pilot studies in patients with other types of cancers such as multiple melanoma and breast cancer. The results were published recently in the renowned journal Proceedings of the National Academy of Sciences of the USA. This is a first in the field of development of cancer vaccines. It is an ideal starting point for a larger phase 2 study with a larger group of AML patients getting benefits forms such form of vaccinations.

Article Source: http://www.cancer-surgery.com/


About Author / Additional Info:


Comments on this article: (0 comments so far)

Comment Comment By Comment Date

Leave a Comment   |   Article Views: 1889



Additional Articles:
•   Preventive Factors of Pancreatic Cancer
•   Tinnitus Heal - Your Research For a Treatment Method
•   Diet For Breast Cancer Clients
•   How Obesity is Related to Pancreatic Cancer?

Latest Articles in "Leukemia" category:
•   The Symptoms of Leukemia is Most General
•   A Brief Introduction to Leukemia: One of Worst Forms of Cancer
•   Healthy Diet Reduces the Occurrence of Leukemia
•   Various Classifications of Leukemia Can Help in its Possible Treatment
•   Patients and Their Family Need to Embrace Everything About Leukemia
•   How Green Tea is Good For Treating Leukemia
•   Possibility of Treatment of Leukemia


Important Disclaimer: All articles on this website are for general information only and is not a professional or experts advice. We do not own any responsibility for correctness or authenticity of the information presented in this article, or any loss or injury resulting from it. We do not endorse these articles, we are neither affiliated with the authors of these articles nor responsible for their content. Please see our disclaimer section for complete terms.
Page copy protected against web site content infringement by Copyscape
Copyright © 2010 cancer-surgery.com - Do not copy articles from this website.
| Home | Disclaimer | Xhtml |